1. Home
  2. MRVI vs CURV Comparison

MRVI vs CURV Comparison

Compare MRVI & CURV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • CURV
  • Stock Information
  • Founded
  • MRVI 2014
  • CURV 2001
  • Country
  • MRVI United States
  • CURV United States
  • Employees
  • MRVI 560
  • CURV N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • CURV Clothing/Shoe/Accessory Stores
  • Sector
  • MRVI Health Care
  • CURV Consumer Discretionary
  • Exchange
  • MRVI Nasdaq
  • CURV Nasdaq
  • Market Cap
  • MRVI 350.1M
  • CURV 215.9M
  • IPO Year
  • MRVI 2020
  • CURV 2021
  • Fundamental
  • Price
  • MRVI $2.42
  • CURV $2.16
  • Analyst Decision
  • MRVI Hold
  • CURV Hold
  • Analyst Count
  • MRVI 10
  • CURV 4
  • Target Price
  • MRVI $5.84
  • CURV $4.00
  • AVG Volume (30 Days)
  • MRVI 1.5M
  • CURV 482.6K
  • Earning Date
  • MRVI 08-11-2025
  • CURV 09-04-2025
  • Dividend Yield
  • MRVI N/A
  • CURV N/A
  • EPS Growth
  • MRVI N/A
  • CURV N/A
  • EPS
  • MRVI N/A
  • CURV 0.09
  • Revenue
  • MRVI $219,830,000.00
  • CURV $1,089,931,000.00
  • Revenue This Year
  • MRVI N/A
  • CURV N/A
  • Revenue Next Year
  • MRVI $7.23
  • CURV N/A
  • P/E Ratio
  • MRVI N/A
  • CURV $24.08
  • Revenue Growth
  • MRVI N/A
  • CURV N/A
  • 52 Week Low
  • MRVI $1.67
  • CURV $2.08
  • 52 Week High
  • MRVI $9.60
  • CURV $7.25
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 49.60
  • CURV 35.39
  • Support Level
  • MRVI $2.28
  • CURV $2.13
  • Resistance Level
  • MRVI $2.47
  • CURV $2.24
  • Average True Range (ATR)
  • MRVI 0.14
  • CURV 0.10
  • MACD
  • MRVI -0.01
  • CURV 0.05
  • Stochastic Oscillator
  • MRVI 27.45
  • CURV 38.30

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About CURV Torrid Holdings Inc.

Torrid Holdings Inc is a direct-to-consumer brand of apparel, intimates, and accessories in North America. The company is focused on fit and offers high-quality products across a broad assortment that includes tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of the e-commerce platform and stores. The company generates revenue from the sale of apparel, intimates, and accessories through its e-commerce platform and its store locations.

Share on Social Networks: